Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
Gkoutzourelas A, Liaskos C, Mytilinaiou MG, Simopoulou T, Katsiari C, Tsirogianni A, Daoussis D, Scheper T, Meyer W, Bogdanos DP, Sakkas LI.
Gkoutzourelas A, et al. Among authors: katsiari c.
Front Immunol. 2018 Dec 7;9:2835. doi: 10.3389/fimmu.2018.02835. eCollection 2018.
Front Immunol. 2018.
PMID: 30581434
Free PMC article.